Home / Health / Glucose Monitors Boost Type 2 Diabetes Control
Glucose Monitors Boost Type 2 Diabetes Control
19 Oct
Summary
- Continuous monitors significantly improve blood sugar control for diabetics.
- Users gained five extra hours daily within target blood sugar range.
- 68% of monitor users achieved an A1C below 7.5% in six months.
A recent clinical trial suggests continuous glucose monitors (CGMs) significantly enhance blood sugar management for people with type 2 diabetes who are not yet on insulin therapy. The study, published on October 14, 2026, found that nearly double the number of participants using CGMs reached their blood sugar treatment targets.
Adults utilizing these devices averaged an additional five hours each day within their optimal blood sugar range. Researchers hope this evidence will influence national diabetes care guidelines and expand insurance coverage for this technology.
For the trial, 283 Americans with type 2 diabetes participated. Roughly half were equipped with CGMs, which track blood sugar day and night, offering insights into how diet and activity affect levels. The remaining participants relied on traditional finger-stick testing.
After six months, 68% of CGM users achieved an A1C below 7.5%, with almost half reaching below 7%. This represents a substantial improvement, offering compelling evidence for earlier consideration of CGMs in type 2 diabetes management even before insulin is required.
